Central Trust Company’s Nutex Health NUTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-133
Closed -$4.05K 1409
2023
Q3
$4.05K Hold
133
﹤0.01% 1165
2023
Q2
$8.43K Hold
133
﹤0.01% 1047
2023
Q1
$20.2K Buy
133
+100
+303% +$20.3K ﹤0.01% 940
2022
Q4
$9.5K Buy
+33
New +$6.34K ﹤0.01% 1016

Other funds holding NUTX

Central Trust Company's NUTX Position: Q4 2023 in Review

Central Trust Company sold out of Nutex Health (NUTX) in Q4 2023, closing a stake of 133 shares — an estimated $4.05K sold.

Central Trust Company first reported a position in NUTX in Q4 2022 and held it in 4 quarters. The position peaked at $20.2K in Q1 2023. 49 funds tracked by Wall St. Rank hold NUTX as of Q4 2023.

  • Central Trust Company reported no remaining Nutex Health position as of Q4 2023 after selling out during the quarter.
  • Central Trust Company sold 133 Nutex Health shares in Q4 2023, an estimated $4.05K.
  • Central Trust Company first reported a position in Nutex Health in Q4 2022 and held it in 4 quarters.
  • Central Trust Company's Nutex Health position peaked at $20.2K in Q1 2023.
  • 49 funds tracked by Wall St. Rank held Nutex Health as of Q4 2023.

Based on Central Trust Company's 13F filing for Q4 2023, filed 24 Jan 2024.